Rocket


News + Filings
Transactions


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Salek-Ardakani Shahram Create: Alert

All | News | Filings
Date FiledTypeDescription
01/05/2022 4 Salek-Ardakani Shahram (Chief Scientific Officer) has filed a Form 4 on Janux Therapeutics, Inc.
Txns: Granted 114,250 options to buy @ $20.24, valued at $2.3M
07/20/2021 3 Form 3 - Initial statement of beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy